Superselective anterior temporal resection in mesial temporal lobe epilepsy

Joacir Graciolli Cordeiro1, Kathrin Wagner, Michael Trippel

  • 1Department of Stereotactic Neurosurgery, University Hospital Freiburg, Freiburg, Germany. joacir.cordeiro@uniklinik-freiburg.de

Insights

This case study highlights a targeted surgical approach for drug-resistant mesial temporal lobe epilepsy (MTLE). Selective resection of the temporal pole and amygdala improved seizure control while preserving cognitive functions.

Area of Science:

  • Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Pharmacoresistant mesial temporal lobe epilepsy (MTLE) poses significant treatment challenges.
  • Early childhood onset of psychomotor seizures necessitates precise localization for effective intervention.

Observation:

  • MRI revealed hippocampal structural changes and mammillary body atrophy.
  • Neuropsychological testing indicated deficits in attention and visual planning.
  • Non-invasive recordings failed to pinpoint the seizure onset zone.

Findings:

  • Invasive monitoring identified seizure onset in the temporo-polar neocortex.
  • Superselective resection of the temporal pole and amygdala, preserving the hippocampus, was performed.
  • Histopathology confirmed focal cortical dysplasia (Palmini type Ib).
  • Post-surgery, seizure frequency decreased, achieving two years of seizure freedom with optimized antiepileptic drugs.

Implications:

  • Highly targeted resections preserving memory-critical structures offer a viable treatment option for selected MTLE patients.
  • This approach balances seizure control with the maintenance of cognitive functions, including memory, attention, and visual planning.

Related Concept Videos